{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T22:07:25Z","timestamp":1771798045676,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd004529.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000}}],"reference-count":52,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004529.pub3","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T13:44:39Z","timestamp":1610977479000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria"],"prefix":"10.1002","volume":"2021","author":[{"given":"Andrew","family":"Blanshard","sequence":"additional","affiliation":[{"name":"Department of Medicine; Norfolk and Norwich University Hospital; Norwich UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Hine","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD004529.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00006454-199905000-00011","article-title":"Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children","volume":"18","author":"Anabwani","year":"1999","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"11","key":"10.1002\/14651858.CD004529.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/379014","article-title":"Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young children","volume":"37","author":"Borrmann","year":"2003","journal-title":"Clinical Infectious Diseases"},{"issue":"5-6","key":"10.1002\/14651858.CD004529.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4269\/ajtmh.2000.63.274","article-title":"Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in non-immune adults: a randomized comparative trial","volume":"63","author":"Bouchaud","year":"2000","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD004529.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4269\/ajtmh.2012.11-0192","article-title":"Randomized, prospective, three-arm study to confirm the auditory safety and efficacy of artemether-lumefantrine in Colombian patients with uncomplicated Plasmodium falciparum malaria","volume":"86","author":"Carrasquilla","year":"2012","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"6","key":"10.1002\/14651858.CD004529.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1086\/516497","article-title":"Atovaquone and proguanil for the treatment of malaria in Brazil","volume":"175","author":"De Alencar","year":"1997","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004529.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-3156.2003.01180.x","article-title":"CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam","volume":"9","author":"Giao","year":"2004","journal-title":"Tropical Medicine and International Health"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1475-2875-7-179","article-title":"Ototoxicity of artemether\/lumefantrine in the treatment of falciparum malaria: a randomized trial","volume":"7","author":"Gurkov","year":"2008","journal-title":"Malaria Journal"},{"issue":"8","key":"10.1002\/14651858.CD004529.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"e42284","DOI":"10.1371\/journal.pone.0042284","article-title":"A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria","volume":"7","author":"Laufer","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"10.1002\/14651858.CD004529.pub3-BIB0009|cit9","first-page":"67","article-title":"Atovaquone and proguanil hydrochloride compared with chloroquine or pyrimethamine\/sulfadoxine for treatment of acute Plasmodium falciparum malaria in Peru","volume":"5","author":"Llanos-Cuentas","year":"2001","journal-title":"Brazilian Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD004529.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4269\/ajtmh.1999.60.526","article-title":"Efficacy and safety of atovaquone\/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand","volume":"60","author":"Looareesuwan","year":"1999","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"5","key":"10.1002\/14651858.CD004529.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/432551","article-title":"A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy","volume":"192","author":"McGready","year":"2005","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD004529.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0149-2918(99)80006-X","article-title":"Atovaquone and proguanil versus pyrimethamine\/sulfadoxine for the treatment of acute falciparum malaria in Zambia","volume":"21","author":"Mulenga","year":"1999","journal-title":"Clinical Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD004529.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1365-3156.2006.01726.x","article-title":"A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children","volume":"11","author":"Mulenga","year":"2006","journal-title":"Tropical Medicine & International Health"},{"issue":"9014","key":"10.1002\/14651858.CD004529.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(96)90671-6","article-title":"Atovaquone and proguanil for Plasmodium falciparum malaria","volume":"347","author":"Radloff","year":"1996","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD004529.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/infdis\/jiu341","article-title":"Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children","volume":"210","author":"Tahar","year":"2014","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004529.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4269\/ajtmh.2005.73.267","article-title":"Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate","volume":"73","author":"Gupta","year":"2005","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"12","key":"10.1002\/14651858.CD004529.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1086\/344901","article-title":"Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil","volume":"35","author":"Van Vugt","year":"2002","journal-title":"Clinical Infectious Diseases"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD004529.pub3-BIB0018|cit18","first-page":"459","article-title":"Therapeutic efficacy of atovaquone-proguanil and artesunate atovaquone-proguanil for the treatment of uncomplicated Plasmodium falciparum malaria in areas of multidrug resistance in Cambodia","volume":"93","author":"Lon","year":"2015","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0019|cit19","unstructured":"The ASAP study - therapeutic efficacy of atovaquone-proguanil vs. artesunate-atovaquone-proguanil in Cambodia (ASAP) clinicaltrials.gov\/ct2\/show\/record\/NCT02297477"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0020|cit20","first-page":"466","article-title":"Update on the asexual and sexual stage-efficacy of atovaquone-proguanil and single low dose primaquine with or without artesunate in Cambodia","volume":"95 (5 Suppl 1)","author":"Wojnarski","year":"2016","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"9","key":"10.1002\/14651858.CD004529.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"ofz314","DOI":"10.1093\/ofid\/ofz314","article-title":"Atovaquone-proguanil in combination with artesunate to treat multidrug-resistant P. falciparum malaria in Cambodia: an open-label randomized trial","volume":"6","author":"Wojnarski","year":"2019","journal-title":"Open Forum Infect Diseases"},{"issue":"6","key":"10.1002\/14651858.CD004529.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1086\/314770","article-title":"Atovaquone-proguanil compared with chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines","volume":"179","author":"Bustos","year":"1999","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004529.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4269\/ajtmh.2005.73.267","article-title":"Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate","volume":"73","author":"Gupta","year":"2005","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"5","key":"10.1002\/14651858.CD004529.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10156-006-0465-8","article-title":"Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan","volume":"12","author":"Hitani","year":"2006","journal-title":"Journal of Infection and Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD004529.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4269\/ajtmh.2007.76.655","article-title":"Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand","volume":"76","author":"Krudsood","year":"2007","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD004529.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4269\/ajtmh.1996.54.62","article-title":"Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand","volume":"54","author":"Looareesuwan","year":"1996","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0027|cit27","unstructured":"Advisory Committee on Malaria Prevention Guidelines for malaria prevention in travellers from the UK PHE Advisory Committee for Malaria Prevention for UK Travellers (ACMP) 2017"},{"issue":"8","key":"10.1002\/14651858.CD004529.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm.4381","article-title":"Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic","volume":"23","author":"Blasco","year":"2017","journal-title":"Nature Medicine"},{"issue":"8","key":"10.1002\/14651858.CD004529.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1128\/AAC.02550-13","article-title":"Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports","volume":"58","author":"Cottrell","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"10.1002\/14651858.CD004529.pub3-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010678.pub2","article-title":"Artemether for severe malaria","author":"Esu","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD004529.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1475-2875-10-339","article-title":"Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator","volume":"10","author":"Flegg","year":"2011","journal-title":"Malaria Journal"},{"issue":"6283","key":"10.1002\/14651858.CD004529.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1126\/science.aad9279","article-title":"Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes","volume":"352","author":"Goodman","year":"2016","journal-title":"Science"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0033|cit33","unstructured":"McMaster University GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0034|cit34","unstructured":"Higgins JP, Altman DG, Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/1475-2875-13-452","article-title":"Artemisinin resistance - modelling the potential human and economic costs","volume":"13","author":"Lubell","year":"2014","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0036|cit36","unstructured":"Medical Dictionary for Regulatory Activities MedDRA Browser"},{"issue":"7","key":"10.1002\/14651858.CD004529.pub3-BIB0037|cit37","first-page":"e10000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement","volume":"6","author":"Mohor","year":"2009","journal-title":"PLoS Medicine"},{"issue":"24","key":"10.1002\/14651858.CD004529.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of artemisinin-resistant malaria in western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD004529.pub3-BIB0039|cit39","first-page":"817","article-title":"A public-private partnership for malaria control: lessons from the Malarone Donation Programme","volume":"80","author":"Oyediran","year":"2002","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0040|cit40","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0041|cit41","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A editors GRADE Working Group GRADE handbook for grading quality of evidence and strength of recommendations Available from guidelinedevelopment.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD004529.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jac\/dkx431","article-title":"Clinical implications of Plasmodium resistance to atovaquone\/proguanil: a systematic review and meta-analysis","volume":"73","author":"Staines","year":"2017","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"11","key":"10.1002\/14651858.CD004529.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1128\/AAC.48.11.4271-4280.2004","article-title":"In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up","volume":"48","author":"Stepniewska","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2046-4053-3-54","article-title":"Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram","volume":"3","author":"Stovold","year":"2014","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0045|cit45","unstructured":"World Health Organization Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria, 2003 www.who.int\/malaria\/publications\/atoz\/whohtmrbm200350\/en\/"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0046|cit46","unstructured":"World Health Organization Methods for surveillance of antimalarial drug efficacy, 2009 www.who.int\/malaria\/publications\/atoz\/9789241597531\/en\/"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0047|cit47","unstructured":"World Health Organization Global plan for artemisinin resistance containment (GPARC), 2011 www.who.int\/malaria\/publications\/atoz\/9789241500838\/en\/"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0048|cit48","unstructured":"World Health Organization Update of artemisinin resistance - April 2012 www.who.int\/malaria\/publications\/atoz\/updateartemsininresistanceapr2012\/en\/"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0049|cit49","unstructured":"World Health Organization Guidelines for the treatment of malaria - 3rd edition, 2015 www.who.int\/publications\/i\/item\/9789241549127"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0050|cit50","unstructured":"World Health Organization World malaria report, 2017 www.who.int\/malaria\/publications\/world-malaria-report-2017\/en\/"},{"key":"10.1002\/14651858.CD004529.pub3-BIB0051|cit51","unstructured":"WHO Global Malaria Programme Artemisinin resistance and artemisinin-based combination therapy efficacy, 2019 www.who.int\/docs\/default-source\/documents\/publications\/gmp\/who-cds-gmp-2019-17-eng.pdf?ua=1"},{"issue":"4","key":"10.1002\/14651858.CD004529.pub3-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004529.pub2","article-title":"Atovaquone-proguanil for treating uncomplicated malaria","author":"Osei-Akoto","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T15:03:34Z","timestamp":1654700614000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004529.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004529.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,18]]}}}